Efficacy of Mamsyadi kwatha ghana add on to cognitive behavioral therapy in the management of vishaada(mild to moderate depressive disorder)among adolescents- A Randomized double blind placebo controlled trial.

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年5月1日

试验速览

暂无简介。

•1. Participants showing signs of Mild to Moderate Depression as per DSM-V Criteria. (PHQ-9 score 5-14).
•2. Participants whose caretakers/parents are willing to provide an informed consent.
•3. Participants providing written informed assent to participate in the study

•1. Patient having severe depression.
•2. Patient having intelligent quotient below 70.
•3. Patient having any severe co-morbid psychiatric disorder especially a diagnosis of bipolar disorder,schizophrenia, autism spectrum disorder, schizoaffective disorder or organic psychiatric disorder assessed by taking detailed history and examination.
•4. Patient having any other medical or neurological conditions or any other illness interfering with interventions.
•5. Participants suffering from any systemic illness, history of epilepsy or chronic illness like hypo or hyperthyroidism.
•6. Substance use disorder or dependency, suicidal ideations.
•7. Current use of Anti-epileptics, anti-psychotic or psychotropic drugs (e.g., Selective
•Serotonin Reuptake Inhibitor, Serotonin and norepinephrine reuptake inhibitors etc.) and
•any other investigational drugs.

发起方